One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Accesshttps://doi.org/10.1182/blood.v130.suppl_1.2684.2684
Copy DOI Journal: Blood |  Publication Date: Jun 25, 2021 |
 Citations: 4 |
Affiliation: Dana-Farber Cancer Institute, Agios Pharmaceuticals (United States), Institut Pasteur, Institut Gustave Roussy, University of Paris-Saclay, Inserm, Institut Polytechnique de Paris, The University of Texas MD Anderson Cancer Center, Memorial Sloan Kettering Cancer Center, Massachusetts General HospitalGenetic Profiling and Deep IDH1 Mutation Clearance to ≤0.04% in Ivosidenib (AG-120)-Treated Patients with Mutant IDH1 Relapsed or Refractory and Untreated AML
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
